
Viveve Medical VIVE
Quarterly report 2022-Q3
added 11-10-2022
Viveve Medical Total Non Current Liabilities 2011-2026 | VIVE
Annual Total Non Current Liabilities Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 498 K | 4.15 M | 31.2 M | 29.3 M | 7.82 M | - | - | 7.22 M | 11.9 M | 6.93 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 31.2 M | 498 K | 12.4 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Align Technology
ALGN
|
184 M | $ 164.43 | -7.28 % | $ 12.3 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 10.89 | -5.47 % | $ 1.63 B | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
196 M | $ 0.39 | 3.7 % | $ 40.1 M | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 104.87 | 0.27 % | $ 183 B | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 34.01 | -3.76 % | $ 5.07 K | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 69.38 | -1.13 % | $ 103 B | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 9.21 | -1.9 % | $ 261 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Electromed
ELMD
|
8.87 K | $ 24.68 | 0.93 % | $ 209 M | ||
|
CONMED Corporation
CNMD
|
877 M | $ 35.31 | -3.64 % | $ 1.1 B | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 56.44 | -5.79 % | $ 1.67 B | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.56 | 0.11 % | $ 122 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 1.93 | -4.0 % | $ 1.17 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 9.24 | -1.49 % | $ 712 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.61 | 1.65 % | $ 33.2 M | ||
|
Aethlon Medical
AEMD
|
42.5 K | $ 2.19 | -3.74 % | $ 3.42 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.44 B | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Inogen
INGN
|
52.5 M | $ 6.29 | -3.31 % | $ 167 M | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 11.13 | -2.45 % | $ 1.5 B | ||
|
LivaNova PLC
LIVN
|
516 M | $ 61.38 | -3.57 % | $ 3.35 B | ||
|
Medtronic PLC
MDT
|
29.6 B | $ 87.08 | 0.14 % | $ 112 B | ||
|
MiMedx Group
MDXG
|
65.4 M | $ 3.92 | -0.51 % | $ 579 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 15.81 | -3.33 % | $ 371 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.19 | -3.52 % | $ 128 M | ||
|
InspireMD
NSPR
|
3.49 M | $ 1.6 | -7.51 % | $ 103 M | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
4.53 M | - | 10.0 % | $ 610 K |